A presenter at the Crohn’s and Colitis Congress highlighted the importance of biomarkers in determining disease activity in inflammatory bowel disease, especially in the era of COVID-19.

“Calprotectin is the most useful biomarker available certainly for the current COVID-19 pandemic but absolutely also beyond the pandemic,” Britta Siegmond, Dr. Med, from Charité, Berlin University of Medicine, said during her presentation.

One recent study showed calprotectin was a good biomarker when evaluating calprotectin in ulcerative colitis. Another study evaluated different types

Full Article: https://www.healio.com/news/gastroenterology/20210122/calprotectin-most-useful-biomarker-for-ibd-during-covid19